Searched for
GERMAN DRUG MAKER
Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGCIndian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...- CEOs are getting ruthless about worker performanceCorporate leaders are increasingly prioritizing results over employee comfort, with CEOs like Unilever's Fernando Fernandez demanding "volu...
- Sun Pharma to acquire Organon for $11.75 billion in India’s biggest pharma dealSun Pharma, led by Dilip Shanghvi, has agreed to acquire US-based Organon in an all-cash deal worth $11.75 billion, marking the largest acq...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- Himachal Pradesh high court restrains DRL from selling BI's diabetic drug JardianceThe drugmaker said it is reviewing legal options including filing an appeal against the court order. Dr Reddy's has launched copies of Jard...
- Boehringer Ingelheim gets interim injunction against Dr. Reddy’s Labs, MSN Labs against copies of anti-diabetes drugIn a statement to ET, BI confirmed it has obtained separate orders granting ad-interim injunction that restrains the two domestic pharmaceu...
- Sun Pharma's subsidiary files patent infringement suit against German drug maker BiofronteraDUSA has alleged that Biofrontera defendants misappropriated confidential and trade secret information from DUSA and improperly obtained co...
- Delhi High Court favours Natco, Alembic; allows them to export generics of Bayer's drugsBayer had approached court in 2016 to stop Alembic Pharmaceuticals from exporting its generic of the German company's blood thinner brand '...
- Merck merges pharma, consumer health units; aims to ramp up businessesGoing against the grain: With the unique hybrid model for India, co aims at building scale & ramping up businesses.
- Boehringer Ingelheim hid key info in petition, says GennovaGennova’s stroke medicine — tenecteplase — was approved by an expert committee of the Central Drugs Standard Control Organisation (CDSCO) i...
- Action between Boehringer Ingelheim and Gennova over stroke medicine moves to courtThe approval of tenectaplase for use in stroke patients has been a point of contention between German drug maker Boehringer Ingelheim and G...
- German drug maker Merck KGaA finds Indian market promising for its pharma, consumer health businessMerck KGaA, the family-controlled $12.5-billion German drug maker, has identified India as one of its key markets under aglobal expansion s...
- Compulsory licensing hit India’s image: Hetero PharmaHyderabadbased Hetero Pharma said that the country has lost nearly $10 billion worth of investment by not respecting IP norms.
- Pharma companies should have clear rules for business in India: GermanyBahr advocating stronger cooperation between Indian and Germany in the health sector, especially in immigration of medical and nursing prof...
- Bayer petition against Natco over manufacture of Nexavar dismissedIntellectual Property Appellate Board of Chennai dismissed Bayer's plea, seeking a stay on Compulsory License issued to Natco to make Nexav...
- Sun Pharma up 3% on bourses on news of tie up with US drug coShares of Sun Pharma touched Rs 455.90, a jump of 3 per cent over its previous closing price on the Bombay Stock Exchange.
- Cipla's clone of Bayer cancer drug gets nodThis case was keenly watched by both pharma industry and health activists because it had much wider ramifications.
- Dr Reddy's could face margin pressure in GermanyLeading Indian drug makers with a large presence in Germany could face substantial pressure on margins following a recent tender by a Germa...
- Singapore firm to acquire 73.27% stake in Dabur PharmaHome grown drug maker Dabur Pharma on Saturday said it will sell 73.27 per cent stake to Fresenius Kabi (Singapore) Pte Ltd for an undisclo...
- Indian herbal drugs may get easier entry into USIndian drug makers, who have so far been restricted to labelling their traditional medicines as dietary supplements in the US, can now clai...
Load More
